Deborah Ellis

SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial

R. Huddart, J. Catto, S. Crabb, 2018, Trials.

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)

R. Huddart, J. Catto, S. Crabb, 2021, Clinical Cancer Research.